ArticleScientific reports2025
Development and validation of a frailty risk model for patients with mild cognitive impairment.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study aims to develop and validate an effective model for predicting frailty risk in individuals with mild cognitive impairment (MCI). The cross-sectional analysis employed nationally representative data from CHARLS 2013-2015. The sample was randomly divided into training (70%) and validation sets (30%). The least absolute shrinkage and selection operator (LASSO) and multivariable logistic regression model were used to identify independent predictors and establish a nomogram to predict the occurrence of frailty. The receiver operating characteristic (ROC) curve, the calibration curve, and the decision curve analysis (DCA) were used to evaluate the performance of the nomogram. A total of 3,196 MCI patients were analyzed, and 803 (25.1%) exhibited symptoms of frailty. Multivariate logistic regression analysis revealed that age, activities of daily living (ADL) score, depression score, grip strength, cardiovascular disease (CVD), liver disease, pain, hearing, and vision were associated factors for frailty in MCI patients. The nomogram based on these factors achieved AUC values of 0.810 (95% CI 0.780, 0.840) in the training set and 0.791 (95% CI 0.760, 0.820) in the validation set. Calibration curves showed good agreement between the nomogram and the observed values. The Hosmer-Lemeshow test results for the training and validation sets were P = 0.396 and P = 0.518, respectively. The ROC curve and decision curve analysis further validated the robust predictive ability of the nomogram. The application of this model may facilitate early clinical interventions, thereby potentially reducing the incidence of frailty among patients with MCI and significantly enhancing their long-term health outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.